Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial

The gold standard endpoint in trials of locoregionally advanced nasopharyngeal carcinoma (NPC) is overall survival (OS). Using data from a phase III randomized trial, we evaluated whether progression-free survival (PFS), failure-free survival (FFS), distant failure-free survival (D-FFS) or locoregio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Pei, Chen, Yong, Zhang, Wen-Na, Liang, Shao-Bo, Zong, Jing-Feng, Chen, Lei, Mao, Yan-Ping, Tang, Ling-Long, Li, Wen-Fei, Liu, Xu, Guo, Ying, Lin, Ai-Hua, Liu, Meng-Zhong, Sun, Ying, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518214/
https://www.ncbi.nlm.nih.gov/pubmed/26219568
http://dx.doi.org/10.1038/srep12502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518214/
https://www.ncbi.nlm.nih.gov/pubmed/26219568
http://dx.doi.org/10.1038/srep12502

Ejemplares similares